A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Biochemically Monoclonal Antibody J591 in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer

Abstract

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 3 subjects. Initial report submitted to WCMC DSMB with recommendation to proceed with enrollment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2010
Accession Number
ADA534816

Entities

People

  • Scott T Tagawa

Organizations

  • Cornell University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Cells
  • Clinical Trials
  • Department Of Defense
  • Diseases And Disorders
  • Electronic Mail
  • Epithelial Cells
  • Medical Personnel
  • Neoplasms
  • New York
  • Physical Properties
  • Prostate
  • Prostate Cancer
  • Radiotherapy
  • Therapy
  • United States

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).